Gaudium IVF IPO: Grab a Slice of Reproductive Healthcare Growth Before 24 February
Gaudium IVF & Women Health Ltd started its first public share sale, which will continue until 24 February 2026. The IPO aims to raise ₹165 crore through an Offer for Sale (OFS) of ₹75 crore and fresh equity worth ₹90 crore. The share price range between ₹75 and ₹79 makes the stock available to both retail investors and institutional investors.
This IPO allows you to acquire shares in a company that develops reproductive healthcare solutions, which will list on both the BSE and NSE.
Do you want to know how the system functions or what value the subscription holds? Investors monitor three main factors, which include subscription trends, grey market activity, and allotment chances. Will early subscribers cash in on potential listing gains? The decision deadline approaches because the window closes on 24 February.
Gaudium IVF IPO Details: Subscription, Price Band, and Use of Proceeds
| Parameter | Details |
|---|---|
| IPO Company | Gaudium IVF & Women Health Ltd |
| IPO Open Date | 20 February 2026 |
| IPO Close Date | 24 February 2026 |
| Total IPO Size | ₹165 crore |
| Offer for Sale (OFS) | ₹75 crore |
| Fresh Issue | ₹90 crore |
| Price Band | ₹75–₹79 per share |
| Listing | BSE & NSE |
| Subscription Status (Day 2, 10:21 AM) | Overall: 1.32x |
| Retail Portion | 1.91x |
| NII Segment | 1.71x |
| Net Proceeds Usage | Funding capital expenditure for new IVF centres, repayment/pre-payment of loans, general corporate purposes |
Gaudium IVF IPO GMP Buzz
The excitement is real! Gaudium IVF shares are already trading at an ₹8.50 premium in the grey market, which indicates a potential listing gain of 11%. The IPO provides investors with a profitable opportunity, as early birds could receive substantial returns.
Gaudium IVF IPO Net Proceeds
The fresh issue proceeds will be used for:
-
Funding capital expenditure for new IVF centres.
-
Repayment or pre-payment of certain outstanding loans.
-
General corporate purposes.
(With Inputs)